Item 2.02 Results of Operations and Financial Condition.

On October 29, 2009, Anadys Pharmaceuticals, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2009. A copy of this press release is attached hereto as Exhibit 99.1, which is furnished under Item 9.01 of this report and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filings.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated October 29, 2009.

---

Top of the Form